MHLW Panel Concludes Novartis Systematically Involved in Diovan Trials: Report

March 28, 2014
The Ministry of Health, Labor and Welfare’s (MHLW) panel of experts has determined that Novartis Pharma systematically played a part in discredited investigator-initiated studies on its best-seller blood pressure drug Diovan (valsartan), a draft report shows. In the draft report...read more